| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 371.11B | 378.81B | 373.57B | 354.92B | 290.42B | 233.60B |
| Gross Profit | 47.42B | 46.48B | 46.30B | 38.88B | 22.86B | 20.59B |
| EBITDA | 52.93B | 51.94B | 53.82B | 50.02B | 34.47B | 30.26B |
| Net Income | 9.17B | 18.56B | 14.14B | 17.10B | 10.01B | 11.00B |
Balance Sheet | ||||||
| Total Assets | 355.30B | 389.39B | 371.09B | 365.52B | 339.38B | 320.01B |
| Cash, Cash Equivalents and Short-Term Investments | 59.58B | 68.85B | 71.06B | 56.63B | 49.92B | 50.10B |
| Total Debt | 48.16B | 45.45B | 51.14B | 50.81B | 57.46B | 64.55B |
| Total Liabilities | 134.79B | 142.10B | 147.82B | 148.80B | 144.82B | 139.54B |
| Stockholders Equity | 216.87B | 243.46B | 219.65B | 213.24B | 191.10B | 176.75B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.38B | 19.44B | 16.43B | 7.99B | 17.56B |
| Operating Cash Flow | 0.00 | 35.16B | 52.25B | 38.77B | 25.23B | 38.60B |
| Investing Cash Flow | 0.00 | -16.60B | -44.55B | -26.54B | -18.26B | -18.50B |
| Financing Cash Flow | 0.00 | -12.07B | -4.41B | -12.06B | -9.57B | -12.46B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥676.40B | 17.63 | ― | 2.60% | 1.89% | -39.75% | |
74 Outperform | ¥543.49B | 8.11 | 8.58% | 2.62% | 8.21% | 72.79% | |
72 Outperform | ¥140.25B | 6.32 | 7.55% | 3.36% | 1.40% | 35.05% | |
66 Neutral | ¥621.55B | -13.88 | 3.35% | 3.18% | 2.15% | -6.81% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥1.79T | 6.16 | 8.34% | 2.03% | 4.53% | 65.12% | |
55 Neutral | ¥351.39B | 135.95 | ― | 1.93% | <0.01% | -83.75% |